نتایج جستجو برای: occult hepatitis

تعداد نتایج: 136332  

2011
Mesut Akarsu Funda Ugur Kantar A Arzu Sayiner

We read with great interest the article, “efficacy of hepatitis B vaccine in those who lost hepatitis B surface antigen during follow-up” by Taheri et al. published in Hepatitis Monthly (1). In this article, the authors assessed the efficacy of HBV vaccine in those who lost their HBsAg without seroconverssion to anti-HBs antibody with no detectable anti-HBs antibody and HBV DNA in their sera. T...

2013
Ming-Ling Chang Yu-Jr Lin Chee-Jen Chang Charisse Yeh Tse-Ching Chen Ta-Sen Yeh Wei-Chen Lee Chau-Ting Yeh

OBJECTIVE AND BACKGROUND The roles of chronic hepatitis B virus (HBV) co-infection (CI) in carcinogenesis of hepatitis C virus (HCV)-associated hepatocellular carcinoma (HCC) remained controversial. To gain new insights into this issue, we investigated the postoperative prognostic value of HBVCI in HCV-associated HCC. METHODS A study cohort of 115 liver tissues obtained from the noncancerous ...

2017
Abeer Elkady Sayuki Iijima Sahar Aboulfotuh Elsayed Mostafa Ali Douaa Sayed Nashwa M Abdel-Aziz Amany M Ali Shuko Murakami Masanori Isogawa Yasuhito Tanaka

AIM To investigate the prevalence and virological characteristics of occult hepatitis B virus (HBV) infections in patients with hematological malignancies in South Egypt. METHODS Serum samples were collected from 165 patients with hematological malignancies to monitor titers of HBV DNA, hepatitis B surface antigen (HBsAg), and antibodies to HBV core (anti-HBc) and surface antigens. Serum samp...

2012
Gian Paolo Caviglia Maria Lorena Abate Paola Manzini Franca Danielle Alessia Ciancio Chiara Rosso Antonella Olivero Rinaldo Pellicano Giovanni Antonio Touscoz Antonina Smedile Mario Rizzetto

BACKGROUND Occult hepatitis B virus infection (OBI) is defined as the presence of hepatitis B virus (HBV) DNA in the liver and/or in the serum of patients with negative results of hepatitis B s antigen (HBsAg) test with or without serological markers of previous viral exposure. The impact of OBI in patients with chronic hepatitis C (CHC) is still unclear. OBJECTIVES The Aim of this study was ...

2014
Yong Liu Jian Wen Jie Chen Chenyu Xu Yali Hu Yi-Hua Zhou

The prevalence of occult Hepatitis B virus (HBV) infection in children was considerably varied from 0.1-64% in different reports. In this study we aimed to investigate the prevalence of occult HBV infection among the children born to mothers with positive hepatitis B surface antigen (HBsAg) in Jiangsu, China. Serum samples were collected from 210 children of 207 mothers with positive HBsAg. HBV...

2013
Violeta Molagic Raluca Mihăilescu Cristina Popescu Cătălin Tilişcan Mihaela Rădulescu Raluca Năstase Ruxandra Moroti Viorica Poghirc Victoria Aramă

Background Hepatitis B virus reactivation (HBV-R) is becoming an increasingly concerning issue as monoclonal antibody therapy has become widely used for chronic lymphoproliferations. HBV-R can also occur in HBsAg negative patients who have only HBcAb positive (occult HBV infection). We present a non-consecutive HBV-R case series report. Our series consisted of both HBsAg positive patients and p...

2016

we note with pleasure that Dr. Osier gives no countenance to the list of occult malarial affections such as neuralgia, paludal hepatitis and paludal pneumonia. He says that if the practitioner will take to heart the lesson that an intermittent fever which resists quinine is not malarial he will avoid many errors in diagnosis. As regards the " whole series of minor ailments attributed to the occ...

2007
Michael A. Purdy

Hepatitis B virus (HBV) can be classified into nine immunological subtypes or eight genotypes. The most prevalent genotypes in Asia are genotypes B and C. HBV is transmitted parenteraly and can produce either asymptomatic or symptomatic disease. Although the consequences of acute hepatitis B can be severe, serious sequelae are associated with chronic infections. HBV seroprevalence ranges from i...

2011
Murat Sayan

I read with great interest the paper by Taheri et al. published in (1) Hepatitis Monthly (Number 31, February 2011). The results of this follow-up study are hopeful of hepatitis-B vaccine efficacy in patients who lost HBsAg and did not seroconvert to anti-HBs with no detectable HBV DNA. However, the editorial in the same issue, as well as Taheri et al. themselves, noted some important limitatio...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید